Bingzhi Zhang, Ph.D.
Affiliations: | 2013 | Biostatistics | Columbia University, New York, NY |
Area:
BIOSTATISTICAL METHODS, EDUCATION, GLOBAL HEALTHGoogle:
"Bingzhi Zhang"Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Castro M, Rabe KF, Corren J, et al. (2020) Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma. Erj Open Research. 6 |
| Castro M, Corren J, Pavord ID, et al. (2018) Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma. The New England Journal of Medicine |
| Busse WW, Maspero JF, Rabe KF, et al. (2018) Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma. Advances in Therapy |
| Busse W, Maspero JF, Katelaris CH, et al. (2018) Dupilumab improves SNOT-22 scores in asthma patients with chronic rhinosinusitis or nasal polypsosis (CRS/NP) in LIBERTY ASTHMA QUEST European Respiratory Journal. 52 |
| Wenzel S, Swanson B, Teper A, et al. (2016) Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients European Respiratory Journal. 48 |
| Huang ZY, Cheng BJ, Cai GJ, et al. (2015) Association of the IL-4R Q576R polymorphism and asthma in the Chinese Han population: a meta-analysis. Genetics and Molecular Research : Gmr. 14: 2900-11 |
| Wenzel S, Castro M, Zhang B, et al. (2015) LATE-BREAKING ABSTRACT: A dose-ranging study of dupilumab in patients (pts) with uncontrolled asthma despite use of inhaled corticosteroids plus a long-acting beta-agonist (ICS/LABA): Final data European Respiratory Journal. 46 |